Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease

Leukemia

Volumn 26, Issue 7, 2012, Pages 1471-1474

  Bossard, C ^a,b   Malard, F ^c,d   Arbez, J ^e,f   Chevallier, P ^d   Guillaume, T ^d   Delaunay, J ^d   Mosnier, J F ^a,b   Tiberghien, P ^e,f,g   Saas, P ^e,f,g   Mohty, M ^c,d,h   Gaugler, B ^a,e,f,g  

^a UNIVERSITÉ DE NANTES   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c Team 12   (France)

^d UNIVERSITÉ DE NANTES   (France)

^e ETABLISSEMENT FRANÇAIS DU SANG   (France)

^f UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^g Plateforme de Biomonitoring   (France)

^h Centre d'Investigation Clinique en Cancé Rologie CI2C   (France)

Author keywords

acute GVHD; plasmacytoid dendritic cells; Th17 cells

Indexed keywords

CD123 ANTIGEN; CD161 ANTIGEN; CHEMOKINE RECEPTOR CCR6; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL ACUTE GRAFT VERSUS HOST DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE MUCOSA; LYMPHOCYTE DIFFERENTIATION; MALE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TH17 CELL;

EID: 84863779459     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.41     Document Type: Article

References (32)

1. Holler E, Kolb HJ, Mittermuller J, Kaul M, Ledderose G, Duell T et al. Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F). Blood 1995; 86: 890-899.
2. Krenger W, Hill GR, Ferrara JL. Cytokine cascades in acute graft-versus-host disease. Transplantation 1997; 64: 553-558.
3. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 2007; 25: 139-170.
4. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 2009; 27: 485-517.
5. Yi T, Zhao D, Lin CL, Zhang C, Chen Y, Todorov I et al. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood 2008; 112: 2101-2110.
6. Kappel LW, Goldberg GL, King CG, Suh DY, Smith OM, Ligh C et al. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 2009; 113: 945-952.
7. Iclozan C, Yu Y, Liu C, Liang Y, Yi T, Anasetti C et al. T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16: 170-178.
8. Carlson MJ, West ML, Coghill JM, Panoskaltsis-Mortari A, Blazar BR, Serody JS. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood 2009; 113: 1365-1374.
9. Yu Y, Wang D, Liu C, Kaosaard K, Semple K, Anasetti C et al. Prevention of GVHD while sparing GVL by targeting Th1 and Th17 transcription factor T-bet and ROR {gamma} t in mice. Blood 2011; 118: 5011-5020.
10. Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, Andre V et al. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation 2009; 88: 1261-1272.
11. Ratajczak P, Janin A, Peffault de Latour R, Leboeuf C, Desveaux A, Keyvanfar K et al. Th17/Treg ratio in human graft-versus-host disease. Blood 2010; 116: 1165-1171.
12. Broady R, Yu J, Chow V, Tantiworawit A, Kang C, Berg K et al. Cutaneous GVHD is associated with the expansion of tissue localised Th1 and not Th17 cells. Blood 2010; 116: 5748-5751.
13. Sale GE, Shulman HM, McDonald GB, Thomas ED. Gastrointestinal graft-versushost disease in man. A clinicopathologic study of the rectal biopsy. Am J Surg Pathol 1979; 3: 291-299.
14. Epstein RJ, McDonald GB, Sale GE, Shulman HM, Thomas ED. The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology 1980; 78: 764-771.
15. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204: 1849-1861.
16. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007; 8: 639-646.
17. Kleinschek MA, Boniface K, Sadekova S, Grein J, Murphy EE, Turner SP et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 2009; 206: 525-534.
18. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126: 1121-1133.
19. Swiecki M, Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 2010; 234: 142-162.
20. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007; 449: 564-569.
21. Gregorio J, Meller S, Conrad C, Di Nardo A, Homey B, Lauerma A et al. Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J Exp Med 2010; 207: 2921-2930.
22. Isaksson M, Ardesjo B, Ronnblom L, Kampe O, Lassmann H, Eloranta ML et al. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE. Eur J Immunol 2009; 39: 2925-2935.
23. Yu CF, Peng WM, Oldenburg J, Hoch J, Bieber T, Limmer A et al. Human plasmacytoid dendritic cells support Th17 cell effector function in response to TLR7 ligation. J Immunol 2010; 184: 1159-1167.
24. Bonnefoy F, Couturier M, Clauzon A, Remy-Martin JP, Gaugler B, Tiberghien P et al. TGF-beta-exposed plasmacytoid dendritic cells participate in Th17 commitment. J Immunol 2011; 186: 6157-6164.
25. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, Cua DJ et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 2011; 12: 255-263.
26. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci USA 2010; 107: 14751-14756.
27. Esplugues E, Huber S, Gagliani N, Hauser AE, Town T, Wan YY et al. Control of TH17 cells occurs in the small intestine. Nature 2011; 475: 514-518.
28. Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V et al. Self-RNAantimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 2009; 206: 1983-1994.
29. Guiducci C, Tripodo C, Gong M, Sangaletti S, Colombo MP, Coffman RL et al. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9. J Exp Med 2010; 207: 2931-2942.
30. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD et al. Imiquimodinduced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 2009; 182: 5836-5845.
31. Mohty M, Blaise D, Faucher C, Vey N, Bouabdallah R, Stoppa AM et al. Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation. Blood 2005; 106: 4407-4411.
32. Platanias LC. Abnormalities in Th17T cells in aplastic anemia. Blood 2010; 116: 4039-4040.